# Sepsis Associated Encephalopathy (SAE) Biomarkers

> **NCT03133208** · — · ACTIVE_NOT_RECRUITING · sponsor: **University of Florida** · enrollment: 90 (estimated)

## Conditions studied

- Sepsis
- Altered Mental Status
- Sepsis-Associated Delirium
- Sepsis Associated Encephalopathy
- Delirium, Sepsis Associated

## Interventions

- **PROCEDURE:** Blood draws

## Key facts

- **NCT ID:** NCT03133208
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-06-01
- **Primary completion:** 2026-12-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03133208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03133208, "Sepsis Associated Encephalopathy (SAE) Biomarkers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03133208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*